Cargando…

Pheochromocytomas and Paragangliomas: Clinical and Genetic Approaches

Pheochromocytomas (PCCs) and paragangliomas (PGLs) are neuroendocrine tumors derived from the chromaffin tissue. Diagnosis of these tumors is extremely important as they are linked to the hypertension syndrome with great cardiovascular morbidity and mortality. A great majority of PCCs and PGLs are s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Costa, Marcia Helena Soares, Ortiga-Carvalho, Tania M., Violante, Alice Dutra, Vaisman, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4538298/ https://www.ncbi.nlm.nih.gov/pubmed/26347711 http://dx.doi.org/10.3389/fendo.2015.00126

Ejemplares similares

Pediatric Metastatic Pheochromocytoma and Paraganglioma: Clinical Presentation and Diagnosis, Genetics, and Therapeutic Approaches
por: Kuo, Mickey J. M., et al.
Publicado: (2022)

Tumour microenvironment in pheochromocytoma and paraganglioma
por: Martinelli, Serena, et al.
Publicado: (2023)

Cancer Stem Cells in Pheochromocytoma and Paraganglioma
por: Scriba, Laura D., et al.
Publicado: (2020)

Genetic and Clinical Profiles of Pheochromocytoma and Paraganglioma: A Single Center Study
por: Ma, Xiaosen, et al.
Publicado: (2020)

Preoperative Management of Pheochromocytoma and Paraganglioma
por: Fang, Fang, et al.
Publicado: (2020)

Pheochromocytoma/paraganglioma-associated cardiomyopathy
por: Szatko, Alicja, et al.
Publicado: (2023)

Clinical differences between small and large pheochromocytomas and paragangliomas
por: Zhao, Lin, et al.
Publicado: (2023)

Pheochromocytomas and Paragangliomas as Causes of Endocrine Hypertension
por: Canu, Letizia, et al.
Publicado: (2019)

Editorial: Predictive tools in pheochromocytoma and paraganglioma
por: Ceccato, Filippo, et al.
Publicado: (2023)

The VHL/HIF Axis in the Development and Treatment of Pheochromocytoma/Paraganglioma
por: Peng, Song, et al.
Publicado: (2020)

Surgical strategies of complicated pheochromocytomas/paragangliomas and literature review
por: Wang, Xu, et al.
Publicado: (2023)

Glycemic Disturbances in Pheochromocytoma and Paraganglioma
por: Ronen, Joshua A, et al.
Publicado: (2019)

Lesion-based indicators predict long-term outcomes of pheochromocytoma and paraganglioma– SIZEPASS
por: Hanschell, Helena, et al.
Publicado: (2023)

Predictive Factors for Catecholamine-Induced Cardiomyopathy in Patients with Pheochromocytoma and Paraganglioma
por: Wang, Yi, et al.
Publicado: (2022)

Editorial: Recent Advances in Pheochromocytoma and Paraganglioma: Molecular Pathogenesis, Clinical Impacts, and Therapeutic Perspective
por: Islam, Farhadul, et al.
Publicado: (2021)

Silent pheochromocytoma and paraganglioma: Systematic review and proposed definitions for standardized terminology
por: Constantinescu, Georgiana, et al.
Publicado: (2022)

Local-Regional Recurrence of Pheochromocytoma/Paraganglioma: Characteristics, Risk Factors and Outcomes
por: Cui, Yunying, et al.
Publicado: (2021)

Biochemical Diagnosis of Catecholamine-Producing Tumors of Childhood: Neuroblastoma, Pheochromocytoma and Paraganglioma
por: Eisenhofer, Graeme, et al.
Publicado: (2022)

SDHB immunohistochemistry for prognosis of pheochromocytoma and paraganglioma: A retrospective and prospective analysis
por: Su, Tingwei, et al.
Publicado: (2023)

Genetics of Pheochromocytomas and Paragangliomas Determine the Therapeutical Approach
por: Sarkadi, Balazs, et al.
Publicado: (2022)

Clinical Presentation and Treatment Outcomes of Children and Adolescents With Pheochromocytoma and Paraganglioma in a Single Center in Korea
por: Park, Hyojung, et al.
Publicado: (2021)

Co-occurrence of mutations in NF1 and other susceptibility genes in pheochromocytoma and paraganglioma
por: Mellid, Sara, et al.
Publicado: (2023)

Treatment for Patients With Malignant Pheochromocytomas and Paragangliomas: A Perspective From the Hallmarks of Cancer
por: Jimenez, Camilo
Publicado: (2018)

Characteristics of Intraoperative Hemodynamic Instability in Postoperatively Diagnosed Pheochromocytoma and Sympathetic Paraganglioma Patients
por: Kim, Jung Hee, et al.
Publicado: (2022)

Factors contributing to development and resolution of dysglycemia in patients with pheochromocytomas and catecholamine-secreting paragangliomas
por: Zhao, Lin, et al.
Publicado: (2023)

Paragangliomas/Pheochromocytomas: Clinically Oriented Genetic Testing
por: Martins, Rute, et al.
Publicado: (2014)

The connection between tricarboxylic acid cycle enzyme mutations and pseudohypoxic signaling in pheochromocytoma and paraganglioma
por: Wang, Yuxiong, et al.
Publicado: (2023)

Cost-minimization analysis of sequential genetic testing versus targeted next-generation sequencing gene panels in patients with pheochromocytoma and paraganglioma
por: Pipitprapat, Weenita, et al.
Publicado: (2021)

Case Report: Composite pheochromocytoma with ganglioneuroma component: A report of three cases
por: Araujo, Paula B., et al.
Publicado: (2022)

Recent Advances in Histopathological and Molecular Diagnosis in Pheochromocytoma and Paraganglioma: Challenges for Predicting Metastasis in Individual Patients
por: Yamazaki, Yuto, et al.
Publicado: (2020)

Somatostatin Receptors and Analogs in Pheochromocytoma and Paraganglioma: Old Players in a New Precision Medicine World
por: Patel, Mayank, et al.
Publicado: (2021)

Prognostic Nomograms for Predicting Overall Survival and Cancer‐Specific Survival of Patients With Malignant Pheochromocytoma and Paraganglioma
por: Zheng, Lei, et al.
Publicado: (2021)

Adrenocortical Tumors and Pheochromocytoma/Paraganglioma Initially Mistaken as Neuroblastoma—Experiences From the GPOH-MET Registry
por: Kuhlen, Michaela, et al.
Publicado: (2022)

Risk Factors for Cardiac Complications in Patients With Pheochromocytoma and Paraganglioma: A Retrospective Single-Center Study
por: Zhao, Lin, et al.
Publicado: (2022)

MON-218 Clinical and Genetic Aspects of Pediatric Pheochromocytomas and Paragangliomas
por: Petenuci, Janaina, et al.
Publicado: (2020)

Clinical Syndromes and Genetic Screening Strategies of Pheochromocytoma and Paraganglioma
por: Liu, Peihua, et al.
Publicado: (2018)

Co-Occurrence of Pheochromocytoma-Paraganglioma and Cyanotic Congenital Heart Disease: A Case Report and Literature Review
por: Zhao, Bingbin, et al.
Publicado: (2018)

Temozolomide Is a Potential Therapeutic Tool for Patients With Metastatic Pheochromocytoma/Paraganglioma—Case Report and Review of the Literature
por: Tong, Anli, et al.
Publicado: (2020)

Influence of duration of preoperative treatment with phenoxybenzamine and secretory phenotypes on perioperative hemodynamics and postoperative outcomes in pheochromocytoma and paraganglioma
por: Yao, Yao, et al.
Publicado: (2023)

Pheochromocytoma and paraganglioma: germline genetics and hereditary syndromes
por: Turin, Christie G, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mu470vg3vkgjm9ve9a7vb7tu51